Partial Penectomy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Partial penectomy is a surgical procedure that removes the distal (front) portion of the penis affected by squamous cell carcinoma (SCC) of the penis — the most common primary penile malignancy — while preserving as much of the remaining penile shaft as possible to maintain functional urination and, in many cases, sexual activity. The procedure achieves clear surgical margins (typically minimum 5–10 mm clear margin) to ensure complete cancer removal, which is critical for local disease control and prevention of recurrence. Penile cancer, though relatively uncommon (accounting for under 1% of male cancers in Western countries, but more prevalent in Africa, Asia, and South America), requires prompt surgical management. Squamous cell carcinoma arises from the squamous epithelium of the glans (head of the penis), prepuce (foreskin), or penile shaft. The surgery is performed by urological surgeons or urological oncologists in oncology centres. Partial penectomy is the preferred approach over total penectomy (full removal) for tumours of the glans and distal shaft where adequate surgical margins can be achieved while leaving a functional penile stump of at least 2–3 cm to allow voiding in a standing position. The European Association of Urology (EAU) guidelines recommend organ-sparing surgery — the least radical procedure achieving clear margins — as the oncological gold standard.

Partial penectomy is indicated for penile squamous cell carcinoma that cannot be adequately managed by organ-sparing approaches. Tumour characteristics determining surgical approach include: stage (pT1 high-grade tumours and pT2 tumours extending into corpus spongiosum or cavernosum have higher recurrence risks requiring wider excision), grade (high-grade G3 tumours require wider margins), location (distal glans or foreskin tumours may be resected as glansectomy alone; proximal or shaft involvement requires partial penectomy), and whether the tumour can be adequately resected with clear margins while preserving a functional stump. Organ-sparing alternatives (laser ablation with Nd:YAG or CO2 laser, Mohs micrographic surgery, glans resurfacing) are appropriate for superficial pTis (carcinoma in situ, erythroplasia of Queyrat) and pTa–pT1a low-grade tumours — reserved for oncology centres with specialised expertise. Human papillomavirus (HPV) — particularly subtypes 16 and 18 — accounts for approximately 50% of penile SCC in developed countries; phimosis (inability to retract the foreskin) and lichen sclerosus (balanitis xerotica obliterans) are additional risk factors. Inguinal lymph node status is critical: clinically lymph-node-positive disease requires inguinal lymphadenectomy (groin node dissection), which significantly affects prognosis.

Under spinal or general anaesthesia, the patient is in the supine position. A tourniquet is applied at the penile base to achieve a bloodless surgical field. The resection line is marked 5–10 mm proximal to the visible or palpable tumour margin — EAU guidelines support a minimum 5 mm negative margin as oncologically adequate for pT1–T2 tumours, a shift from the historical 2 cm margin that necessitated more radical resections. The urethra is divided and spatulated (cut longitudinally) to create a wider urethral opening, and the corpora cavernosa (erectile tissue cylinders) are divided sharply at the planned resection level. Frozen section histological examination is performed on the resection margins to confirm clear margins intraoperatively — if positive margins are identified, the resection is extended. The urethra is sutured to the skin in a careful meatoplasty (creation of a new urethral opening) to produce a wide, slit-like neo-meatus that minimises the risk of urethral stenosis — a significant post-operative complication. A urethral catheter (Foley, 14–16Fr) is left in situ for 1–2 weeks to allow the meatus to heal without stricture. Penile skin is tailored and closed with absorbable sutures. The inguinal lymph nodes are simultaneously assessed by sentinel lymph node biopsy (SLNB) for pathologically lymph-node-positive disease staging.

Partial penectomy achieves cancer control in most cases of resectable penile SCC while preserving maximal penile function. Local recurrence rates after partial penectomy with clear margins are 5–10% at 5 years — equivalent to more radical procedures, validating the oncological adequacy of margin-appropriate partial resection per EAU and AUA guidelines. Patients with a preserved penile stump of over 3 cm retain the ability to void while standing and in many cases can maintain penetrative sexual activity with appropriate support and rehabilitation. Cancer-specific survival is excellent for organ-confined disease: 5-year overall survival for pT1–T2 N0 penile SCC is approximately 80–90%, with the residual mortality attributable primarily to regional lymph node metastases. Partial penectomy preserves significantly more function than total penectomy — a key quality-of-life advantage. Psychosexual outcomes, while substantially affected by any penile surgery, are superior after partial versus total penectomy. Organ-preserving approaches (laser, glansectomy) are preferred where oncologically safe, but partial penectomy achieves necessary margin clearance for more advanced localised disease with excellent durable local control.

Early surgical complications include haematoma (blood collection under the skin, occurring in 5–10%), wound infection (4–7%), wound dehiscence (breakdown), urinary retention from catheter displacement, and bladder spasm. Urethral meatal stenosis (narrowing of the urethral opening causing poor urinary stream) is the most clinically significant long-term complication, occurring in 5–20% of cases — careful meatoplasty technique with a wide spatulated anastomosis minimises but does not eliminate this risk. Stenosis typically presents at 3–6 months as progressively poor stream and may require urethral dilatation or meatotomy (surgical widening). Phantom penile pain — neuropathic pain in the amputated portion — can occur and is treated with gabapentin or amitriptyline. The psychological impact of partial penectomy is significant: anxiety, depression, altered body image, sexual dysfunction, and relationship difficulties are common and require proactive multidisciplinary support including psychosexual counselling and, where appropriate, referral to penile rehabilitation services. Penile prosthetic implantation in the residual stump is possible in selected patients following cancer clearance to improve sexual function. Oncological recurrence risk — local or regional (inguinal nodes) — necessitates regular surveillance.

After partial penectomy, patients are hospitalised for 3–7 days. Pain management uses paracetamol, ibuprofen, and short-course opioids (tramadol or codeine) as required. A urethral catheter remains for 1–2 weeks to allow the meatoplasty to heal without stenosis — catheter care instructions include cleaning the meatus daily and ensuring free catheter drainage. On catheter removal, the urinary stream is assessed — adequate flow confirms absence of early meatal stenosis. Wound care involves daily inspection, gentle cleaning with sterile saline, and absorbable suture management. The patient is warned about expected skin bruising, swelling, and temporary altered sensation. Sexual abstinence is advised for a minimum of 6 weeks to allow complete wound healing. Psychosexual counselling is initiated early in the post-operative period — ideally pre-operatively — addressing body image concerns, relationship impacts, and sexual rehabilitation options. Oncological follow-up is structured per EAU guidelines: physical examination and groin node assessment every 3 months for 2 years, then 6-monthly to 5 years. Sentinel lymph node biopsy result guides need for inguinal lymphadenectomy. Patients are counselled on local recurrence warning signs (new penile lesion, inguinal lump) and advised to present promptly for examination.